Literature DB >> 20403493

Mortality in the TRITON trial: update from the FDA prasugrel action package.

Victor L Serebruany.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20403493     DOI： 10.1016/j.amjcard.2009.12.052

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  2 in total

Review 1.  Clinical impact of genetically determined platelet reactivity.

Authors:  Marc Laine; Sébastien Arméro; Michaël Peyrol; Pascal Sbragia; Franck Thuny; Franck Paganelli; Laurent Bonello
Journal:  J Cardiovasc Transl Res       Date:  2012-11-13       Impact factor: 4.132

2.  Immediate and Long-Term Therapy of Patients with Acute Coronary Syndromes with Thienopyridines. Current Status According to the Latest European Society of Cardiology (ESC) Guidelines.

Authors:  Sigmund Silber
Journal:  Rambam Maimonides Med J       Date:  2011-07-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.